The promise of artificial intelligence for kidney pathophysiology. Issue 4 (10th July 2022)

• Record Type: Journal Article
• Authors: Jiang, Joy; Chan, Lili; Nadkarni, Girish N.
• Is Part Of: Current opinion in nephrology and hypertension. Volume 31:Issue 4(2022)
• Page Start: 380
• Page End: 386
• Publication Date: 2022-07-10
• Subjects: artificial intelligence -- diagnosis -- machine learning -- nephrology -- prognosis; Hypertension -- Periodicals; Nephrology -- Periodicals; Hypertension -- Indexes; Hypertension -- Periodicals; Kidney Diseases -- Indexes; Kidney Diseases -- Periodicals; Nephrology -- Periodicals; 616.132
• DOI: 10.1097/MNH.0000000000000808
• Languages: English
• ISSNs: 1062-4821

Abstract

Abstract : Purpose of review: We seek to determine recent advances in kidney pathophysiology that have been enabled or enhanced by artificial intelligence. We describe some of the challenges in the field as well as future directions. Recent findings: We first provide an overview of artificial intelligence terminologies and methodologies. We then describe the use of artificial intelligence in kidney diseases to discover risk factors from clinical data for disease progression, annotate whole slide imaging and decipher multiomics data. We delineate key examples of risk stratification and prognostication in acute kidney injury (AKI) and chronic kidney disease (CKD). We contextualize these applications in kidney disease oncology, one of the subfields to benefit demonstrably from artificial intelligence using all if these approaches. We conclude by elucidating technical challenges and ethical considerations and briefly considering future directions. Summary: The integration of clinical data, patient derived data, histology and proteomics and genomics can enhance the work of clinicians in providing more accurate diagnoses and elevating understanding of disease progression. Implementation research needs to be performed to translate these algorithms to the clinical setting.